Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
1.62 Mб
Скачать

B I B L I O G R A P H Y

——— “Cataracts and Riboflavin Deficiency.” The American Journal of Clinical Nutrition 34 (1981): 861–63.

Stocker, Frederick W., Lawrence B. Holt, and James W. Clower. “Clinical Experiments with New Ways of Influencing Intraocular Tension. I. Effect of Rice Diet.” Archives of Ophthalmology 40 (1948): 46–55.

Stulting, R. Doyle, Jonathan D. Carr, Keith P. Thompson, George O. Waring III, Wendy M. Wiley, and Judy G. Walker. “Complications of Laser in Situ Keratomileusis for the Correction of Myopia.” Ophthalmology 106 (1999): 13–20.

Stur, Michael, Michael Tittl, Andreas Reitner, and Vanee Meisinger.“Oral Zinc and the Second Eye in Age-Related Macular Degeneration.” Investigative Ophthalmology and Visual Science 37 (1996): 1225–35.

Taylor, Allen, Paul F. Jacques, T. Nowell, G. Perrone, J. Blumberg, G. Handelman, B. Jozwiak, and D. Nadler.“Vitamin C in Human and Guinea Pig Aqueous, Lens and Plasma in Relation to Intake.” Current Eye Research 16 (1997): 857–64.

Van Eck, William F. “The Effect of a Low-Fat Diet on the Serum Lipids in Diabetes and Its Significance in Diabetic Retinopathy.” American Journal of Medicine 27 (1959): 196–211.

Waring, George O., III, Jonathan D. Carr, R. Doyle Stulting, Wendy M. Wiley, David Huang, and Keith P. Thompson. “LASIK for Myopia and Astigmatism in 2,100 Consecutive Eyes Using a Nidek EC-5000 Excimer Laser.” Investigative Ophthalmology and Visual Science 40 (1999): S588.

Yeum, Kyung-Jin, Fu Shang, Wolfgang Schalch, Robert M. Russell, and Allen Taylor. “Fat-Soluble Nutrient Concentrations in Different Layers of Human Cataractous Lens.” Current Eye Research 19 (1999): 502–5.

328

Index

Page references in italic refer to illustrative material

Abrasions, corneal, 11, 83–85, 91 Accommodation, 14, 27, 110, 122 Accommodative esotropia, 110–11 Acne rosacea, 61

Acquired immunodeficiency syndrome. See AIDS

Aging, and presbyopia, 14, 15, 27–28, 40

AIDS (acquired immunodeficiency syndrome) in cytomegalovirus retinitis, 263–66

in eyelid problems, 268–69

in human immunodeficiency virus, 263 in other forms of retinitis, 266–68 recommendations for, 269

retinal problems in, 268 Alcohol

cataracts and, 135 glaucoma and, 159

macular degeneration and, 207 optic nerve damage and, 233

Allergies

acute reactions, 100–101 to contact lens solutions, 50 hay fever, 98–100

to medications, 23 vernal, 101

Alzheimer’s disease, 196 Amblyopia (lazy eye), 109, 111–12

ptosis and, 80 tobacco alcohol, 233

Amino acids, 280–82 Amsler grid, 29, 208, 223–24

Aneurysms, 119, 227, 233, 250 microaneurysms, 177–78, 179

Angiography, fluorescein, 178, 208, 223

Angle-closure glaucoma, 14 surgery for, 167–68

tranquilizers/antidepressants and, 274 types of, 149–50

Angle recession, 35 Ankylosing spondylitis, 242 Anterior chamber, 10, 13, 33

Antibiotics, 23. See also Medications; specific diseases

Anticancer drugs, 274–75 Antidepressants, 273–74 Antihistamines, 99–100

Anti-inflammatory drugs, 271–73. See also Corticosteroids

Antioxidants

carotenoids, 128, 131, 199–200, 201–3, 287 in cataract prevention, 128–33, 143 defined, 125, 198

in gingko biloba, 166 lutein, 131–32, 142, 201–3

macular degeneration and, 197–203, 205 niacin (vitamin B3), 132, 288

in protection of the retina, 198–200 riboflavin (vitamin B2), 132, 287–88 in tea, 133

vitamin C, 125, 129–30, 143, 292 vitamin E, 125, 130–31, 143, 293

Apraclonidine, 153 Aqueous humor, 9, 13, 14

Argon laser trabeculoplasty, 168–69 Arteritis, temporal/giant cell, 218, 230–31 Artery, central retinal

anatomy of, 10, 17–18 occlusions of, 217–20

Arthritis

juvenile rheumatoid, 243

in spine (ankylosing spondylitis), 238, 242

329

Copyright 2001 by Jay B. Levine. Click Here for Terms of Use.

 

I N D E X

Ascorbic acid. See Vitamin C

Blood circulation

Aspirin, 184, 248

in glaucoma, 151, 164–65

Astigmatism

in smokers, 157

defined, 27, 39–40

Blood pressure, 207, 215–17, 220

irregular, 11, 40, 90

Blood sugar

Atherosclerosis, 205

in diabetes, 173, 174–76, 180

Autoimmune diseases

effect on eyes, 176–77

and optic neuritis, 233

Blood vessels, retinal

uveitis, 235–36

anatomy of, 10, 17–18

 

examination of, 34

Bacterial infections

in HIV infections, 267

conjunctivitis, 94, 97–98

occlusions of

in cornea, 90–91

arterial, 5–6, 216, 217–20

of eyelids, 59, 61–62, 63

vein, 216, 220–22

Bandage lens, 85, 88–89

Blood viscosity, 164–65, 166–67

Basal cell carcinomas, 76–77

Blowout fractures, 117

Base-down triangle procedure, 79

Bowman’s membrane, 11

Benign intracranial hypertension, 233

Bruch’s membrane, 16–17, 188

Beta blockers, 151–52, 249

 

Beta-carotene, 200, 201, 287

Caffeine, 157–58

Betaxolol, 151, 152

Calcium, 297–98

Betoptic (betaxolol), 151, 152

Canaliculi, 70

Bifocals, 40–41, 44

Canal of Schlemm, 10, 13

Biomicroscope, 32, 87

Capsule of lens, 16, 123

Biopsies, 218, 230–31

Carbohydrates, 279–80

Biotin, 291

Carbonic anhydrase inhibitors, 154

Bleeding

Carcinomas, 76–77

in anterior chamber, 13

Carotenoids

in hypertensive retinopathy, 216

and macular degeneration, 199–200,

cause of optic nerve damage, 232–33

201–2, 205

on optic disk,147

in preventing cataracts, 128, 131

in retina, 178

and vitamin A, 287

subconjunctival hemorrhage, 105–6

Cataracts

after vein occlusions, 221

and corticosteroids, 135, 271–72

in vitreous humor, 16

crystalline lens in, 122–23, 125–26

Blepharitis (eyelid inflammation)

defined, 1, 16, 121

and allergies, 100

in diabetes, 124, 135, 176

angular, 61

diagnosing, 1, 33

causes of, 60–61

effect on vision, 26, 121–22

and conjunctivitis, 97

formation of, 124–25

defined, 59

hypermature, 122

in dystrophies, 90

prevention of, 126–27

eczematoid, 61

antioxidants in, 128–33, 143

problems caused by, 61–62, 64–65

and dairy foods, 133–35

seborrheic, 59, 62, 63

lutein in, 131–32, 142

staphylococcal, 59, 61–62, 63

vitamin C in, 125, 129–30, 143

susceptibility to, 61

vitamin E in, 130–31, 143

symptoms of, 29–30, 60

vitamin supplements in, 127–28

treating, 62–64

recommendations for, 142–43

Blindness

risk factors for, 127, 135–36

from glaucoma, 145

surgery for, 1, 136–42, 143

legal definition of, 25

alternatives to, 138–39

sudden, 5–6

combining with glaucoma surgery, 169

Blinking, lack of, 255

complications of, 126, 141–42

Blood-aqueous barrier, 160

epidemic of, 136–37

330

I N D E X

incision size in, 140–41 indications for, 137–38 procedure for, 139–40

types of

cortical, 16, 123, 124

nuclear sclerotic, 16, 123, 124, 135 posterior subcapsular, 123, 134, 135,

138, 271 secondary, 142, 211

in uveitis, 238 Cellophane maculopathy, 215 Chalazia

defined, 64

and oil gland tumors, 74–75 susceptibility to, 64–65 treatment of, 65–66

Chemicals in eyes, 5 Children

amblyopia in, 111–12 esotropia in, 2, 108–11 exotropia in, 113–14

getting eyedrops into eyes, 98 glaucoma in, 150

hyperopia in, 109, 110, 111 nutrition in eye health, 268–71 ptosis in, 79–80

tear duct problems in, 70–71 Chlamydial conjunctivitis, 96–97 Cholesterol

drugs to lower, 182, 275

and macular degeneration, 203–5 and retinopathy, 180–82

and zinc, 194–95 Choroid, 9, 10, 16–17, 188, 235 Choroiditis, 17

Chronic angle-closure glaucoma, 149, 274 Chronic open angle glaucoma

blood circulation in, 151 defined, 14, 149, 150

effect of medications on, 273–74 and omega-3 fatty acids in, 165 surgery for, 168–70

Ciliary body

description of, 9, 10, 14, 235 partial destruction of, 170

Clindamycin, 225, 226 CMV. See Cytomegalovirus

Cobalamin (vitamin B12), 233, 289–90 Colitis

pseudomembranous, 226 ulcerative, 242

Color vision, 36 Cones, 17, 188, 269 Congenital disorders

dacryostenosis, 70–71

esotropia, 108, 109–11 glaucoma, 150

Conjunctiva. See also Conjunctivitis anatomy of, 10, 12–13 disorders of

allergies, 98–101 episcleritis, 101–3 pinguecula, 105 pterygium, 103–4

subconjunctival hemorrhage, 105–6

examination of, 33 foreign bodies in, 6, 85–86

Conjunctivitis bacterial, 94, 97–98

caused by herpes simplex, 96, 257 causes of, 93

in children, 98 chlamydial, 96–97 defined, 13

giant papillary, 50–51 phlyctenular, 61–62 viral, 93–96

Contact lenses, 45–51 advantages/disadvantages of, 45–46 after cataract surgery, 140

bandage lens, 85, 88–89 choosing, 48–49

costs of, 49 examination for, 49 and eyes changing, 2 fittings, 49–50 follow-up care, 50 in presbyopia, 47–48

problems with, 7, 11, 50–51, 91 types of, 46–47

Convergence amplitudes, 36–37, 115 Convergence insufficiency, 113–15, 244 Copper, 191–93, 300–301

Cornea

abrasions of, 11, 83–85, 91 anatomy of, 9, 10–12, 10 clouding of, 87–90, 141 edema of, 11–12, 46, 51, 87–89 effect of diabetes on, 176 endothelial cell loss in, 87–88 examination of, 32–33 foreign bodies in, 6, 85–87 infections of, 90–93, 257–59 lacerations to, 11, 85

scarring of, 11 transplantation of, 89 ulcers of, 11, 50, 90–93

Cortex of lens, 15–16, 123 Cortical cataracts, 16, 123, 124

331

I N D E X

Corticosteroids

and cataracts, 135, 271–72 in conjunctivitis, 96

in herpes infections, 258, 259, 262 in optic neuritis, 229

side effects of, 100, 271–72 in temporal arteritis, 231 in toxoplasmosis, 225–26 in uveitis, 240–41

Cotton wool spots, 216 Crohn’s disease, 242 Crossed eyes. See Esotropia Cryotherapy, 170, 212, 213 Crystalline lens. See Lens Crystallins, 123

Cup/disk ratio, 146 Cup of optic disk, 146 Cyclitis, 235 Cyclocryotherapy, 170

Cyst, epithelial inclusion, 74 Cytomegalovirus (CMV), 263–66

Dacryoadenitis, 74 Dacryocystorhinostomy (DCR), 72–73 Dacryostenosis, congenital, 70–71 Dairy foods, 133–35

Dandruff, 62 Dazzle test, 36 Dendrites, 257, 261

Depth perception, 31, 107 Descemet’s membrane, 12

DHA (Docosahexaenoic acid), 270–71 Diabetes mellitus

cataracts in, 124, 135, 176 complications of, 174–77 diet in, 3, 174–76

nerve palsies in, 118 recommendations for, 186 retinopathy in, 177–86

and aspirin, 184

background retinopathy, 177, 179 and cholesterol, 180–82 controlling naturally, 180–83 and diet, 180–82

and gingko biloba, 185–86 hard exudates in, 178, 179–82 laser treatments in, 178–80 and magnesium, 183–84, 299 and omega-3 fatty acids, 185 proliferative, 178

and vitamin E, 184–85 types of, 173–74

Diabetic maculopathy, 179 Diet. See Nutrition Disciform keratitis, 259

Divergence amplitudes, 36–37, 115 Docosahexaenoic acid (DHA), 270–71 Double vision

determining cause of, 116–17 in diabetes, 176

and muscle problems, 117 and nerve palsies, 117–19

and transient ischemic attacks, 120 Drugs. See Medications

Drusen, 188

Dry eye syndrome

with contact lenses, 47 in dystrophies, 90

and laser surgery, 54–55

and reading problems, 121–22 risk factors for, 67

and risk of infection, 91 treatment of, 68–69 types of, 67–68

Duke-Elder, Stewart, 162 Dye disappearance test, 72 Dystrophies

Fuch’s, 87–88 granular, 90 lattice, 90 macular, 90

map-dot fingerprint, 89–90

Early Treatment Diabetic Retinopathy Study (ETDRS), 179

Ectropion, 73, 77–78, 78 Eczematoid blepharitis, 61 Edema

corneal

causes of, 87

and contact lenses, 46, 51 defined, 11–12 diagnosing, 87–88 treating, 88–89

macular, 275 Eicosapentaenoic acid (EPA), 270 Elderly, cholesterol and zinc in, 195 Endothelial cells, 12, 87–89 Entropion, 73, 77–79

EPA (Eicosapentaenoic acid), 270 Epinephrine eyedrops, 152–53 Epiphora, 30, 71

Epiretinal membrane, 214 Episcleritis, 101–3, 106

and blepharitis, 61

in contact lens wearers, 51 Epithelial cells of lens, 123 Epithelial inclusion cyst, 74 Epithelium of cornea, 10–11 Esophoria, 36–37, 115

332

I N D E X

Esotropia, 2 accommodative, 110–11 infantile, 108, 109–11 pseudoesotropia, 108 treating, 109–11

Exercise, aerobic, 156–57, 166 Exercises, eye, 2, 113, 114–15 Exophoria, 36–37, 114, 115 Exophthalmos, 252, 253 Exotropia, 113–15

External hordeolum. See Styes Exudates, hard, 178, 179–82 Eye charts, 24–26

Eye Disease Case-Control Study, 199, 202, 204 Eye diseases. See also specific diseases

prevention with nutrition, 3, 277–79 Eyedrops. See also specific disorders

anesthetic (numbing), 84, 86 artificial tears, 63–64, 68 cycloplegic, 239

in diagnosing disorders, 37 dilating, 84, 138–39 getting into child’s eyes, 98

Eye examinations

for color vision, 36 for contact lenses, 49

convergence and divergence amplitudes, 36–37, 115

of external structures, 29–30 eye movement (motility), 30–31 of fundus, 34–35

gonioscopy, 35, 149 ophthalmodynamometry, 35–36 photo-stress test, 36

pressure check (tonometry), 34, 145–46, 148–49

of pupils, 31, 227 refraction, 26–28

slit lamp exam, 32–33, 87 special eyedrops, 37 visual acuity, 24–26

visual fields, 29, 147–48, 227 Eyeglasses, 39–45

bifocals, 40–41, 44 and eye weakness, 2 frame selection, 42 lenses, 42–45 prescriptions of, 40–41 prisms for, 115 reading glasses, 43, 115

to treat accommodative esotropia, 111 trifocals, 44

wearing too much, 2 Eye history, 21–23 Eyelashes, 30

Eyelids disorders of

chalazia, 64–66, 74–75 ectropion, 73, 77–78 entropion, 73, 77–79 herpes infections, 267

inflammation (blepharitis), 59–64 Kaposi’s sarcoma, 268

molluscum contagiosum, 75, 267–68 ptosis, 79–81

S-shaped deformity, 30, 74 styes, 64–66

tumors, 74–77 twitching, 7–8 examination of, 29–30 lid hygiene/scrubs, 62

Eye movement (motility), 30–31 Eye muscles. See Muscles, eye

Eye ointments. See Ointments, eye Eye pressure. See Intraocular pressure Eyes. See also other Eye entries; specific

disorders anatomy of, 9–10, 10

anterior chamber, 13 choroid, 9, 16–17, 188, 235 ciliary body, 9, 14, 170, 235 conjunctiva, 12–13 cornea, 9, 10–12

external eye muscles, 18–19 iris, 9, 14–15, 235

lens, 15–16 optic nerve, 9, 18 pupil, 15

retina, 9, 17–18, 188 sclera, 9, 12–13

trabecular meshwork, 13–14 vitreous humor, 9, 16

angle of, 149

foreign bodies in, 6, 85–87 motility of, 30–31

weak, 2

Eye socket (orbit), 9

Eye straightness. See Muscles, eye

Farnsworth-Munsell 100 hue test, 36 Farsightedness. See Hyperopia Fasanella-Servat procedure, 81

Fats, animal cholesterol, 180–82 in diet, 278, 283–85

and macular degeneration, 203–6 types of, 283–84

Fatty acids

effect on retinopathy, 185 in infant eye health, 269–71

333

I N D E X

omega-3, 165–66, 284 omega-6, 269, 284

polyunsaturated, 269–71, 283–84 types of, 283–84

Feverfew, 249

Fiber, 285–86

Filtering procedure, 169–70 Flap microstriae, 53

Flare, 33, 237

Flashing lights, 7, 211–12 Flavonoids, 161, 303 Floaters, 7, 211–12

Folic acid (folate), 291 Follicles, 94

Foods. See Nutrition Foreign bodies, 6, 85–87 Fractures, blowout, 117 Free radicals, 125, 198 Fuch’s dystrophy, 87–88 Fundus, 34–35

Fungal infections, 90 Fusion, 31, 113

Galactosemia, 133–34 Genetics, 136, 189

Giant cell arteritis, 218, 230–31

Giant papillary conjunctivitis (GPC), 50–51 Ginkgo biloba

antioxidants in, 166

effect on retinopathy, 185–86 in treatment of uveitis, 241–42

Glasses. See Eyeglasses Glaucoma

and alcohol, 159

angle-closure, 14, 149–50, 167–68, 274 and blood flow, 151, 164–65

and caffeine, 157–58

chronic open angle, 14, 149, 150, 168–70, 273–74

congenital/infantile, 150 described, 145–46

diagnosis of, 1–2, 18, 34, 146–50 and exercise, 156–57

eye pressure checks for, 1–2, 34, 145–46, 148–49

and ginkgo biloba, 166 low-tension, 145–46 medications for, 150–56, 168 neovascular, 221

and omega-3 fatty acids, 165–66 phacolytic, 122

pigmentary, 15, 157 and pilocarpine, 160–61

recommendations for, 170–72 and rice diet, 162–64

and rutin, 160–61 secondary, 150, 272 and smoking, 157 surgery for, 167–70

and timing of meals, 161–62 and vitamin B1, 160

and vitamin C, 159–60 and water intake, 158–59

Glutathione, 125–26 Goldmann perimeter, 147 Goldmann tonometry, 34, 148 Gonioscopy, 35, 149

GPC (Giant papillary conjunctivitis), 50–51 Granular dystrophy, 90

Grave’s disease, 251

Greater occipital neuralgia, 244, 245 Gunn pupil, 227

Guttata, 33, 88

Hay fever, 98–100 Headaches

ice-cream, 246 migraine, 6, 246–50 muscle tension, 244–46 related eye problems, 250

Heart block, 152 Hemoglobin A1c, 174 Hemorrhage. See Bleeding Herpes viruses

and eyelid problems, 267 herpes simplex, 256–60

in conjunctivitis, 96, 257

in corneal infections, 90, 257–59 in eye complications, 259–60 recurrence of, 258–59 treatment of, 257–58

herpes zoster, 119, 260–63 and retinitis, 266

Hirschberg test, 108–9 Histoplasmosis, 222 Histo spots, 222

HIV (Human immunodeficiency virus). See AIDS

Hordeolum. See Chalazia; Styes Horner’s syndrome, 80, 247

Human immunodeficiency virus (HIV). See AIDS

Hydroxychloroquine, 272–73

Hyperopia (farsightedness) in children, 109, 110, 111 defined, 26–27, 39 versus presbyopia, 28

Hypertension

benign intracranial, 233 effect on eye, 215–16

334

I N D E X

and macular degeneration, 207 ophthalmologist in diagnosing, 216–17 retinopathy in, 216, 217

and vein occlusions, 216, 220 Hyperthyroidism, 250, 251–52 Hypothyroidism, 250, 251

IDDM (insulin-dependent diabetes mellitus), 173, 177

Idoxuridine, 258 Immune system, 195–96 Infants

DHA level in, 270–71 esotropia in, 108, 109–11 glaucoma in, 150

nutrition in eye health, 268–71 ptosis in, 79–80

tear duct problems in, 70–71 Infections

after cataract surgery, 141 conjunctivitis, 6, 13, 93–98 corneal, 90–93, 257–59 corneal ulcers, 11, 50, 90–93 determining cause of, 92 herpes, 90, 96, 256–63, 267

human immunodeficiency virus, 263–68 lymph nodes in, 30

molluscum contagiosum, 75, 267–68 periorbital cellulitis, 66 staphylococcal blepharitis, 61–62, 63 in tear sac, 70

toxoplasmosis, 224–26, 243 Inflammation

of choroid (choroiditis), 17 episcleritis, 101–3, 106

of eyelids (blepharitis), 59–64 of iris (iritis), 13, 31, 235

of tear gland (dacryoadenitis), 74 temporal arteritis, 218, 230–31 of uvea (uveitis), 14, 16, 235–43

of vitreous humor (vitritis), 235, 238, 240 Inflammatory bowel disease, 242

Injections, subconjunctival, 240 Injuries

blowout fractures, 117 and cataracts, 136 chemicals in eyes, 5

corneal abrasions, 11, 83–85, 91 corneal lacerations, 11, 85 foreign bodies in eye, 6, 85–87 and optic nerve damage, 232

Insulin-dependent diabetes mellitus (IDDM), 173, 177

Internal hordeolum. See Chalazia Intraocular lens implants, 140

Intraocular pressure (IOP) and alcohol, 159

and caffeine, 157–58 defined, 34

in diagnosing glaucoma, 34, 145–46, 148–49

and diet, 162–63 effect of LASIK on, 55 and exercise, 156–57

lowering with medication, 150–56 and prostaglandins, 163–64

and timing of meals, 161–62 in uveitis, 238

and vein occlusions, 220 and vitamin C, 159–60 and water intake, 158–59

Intrastromal corneal ring segments, 56 Iodine, 302

IOP. See Intraocular pressure Iopidine (apraclonidine), 153 Iridocyclitis, 235, 242 Iridotomy, 167, 274

Iris

anatomy of, 9, 10, 14–15, 235 examination of, 33 inflammation of, 13, 31, 235 rubeosis iridis, 15, 33

Iritis, 13, 31, 235

Iron, 193, 295–97

Ischemic optic neuropathy, 229–32 Isoflavones, 303

Itching, eye. See Allergies

Jones test, 72

Jones tube, 73

Kaposi’s sarcoma, 268

Kempner, Walter, 163, 181

Keratic precipitates, 237

Keratitis, 257, 259

Keratoconus, 90

Keratometer, 49

Lacerations, corneal, 11, 85

Lacrimal system. See Tears; Tear system Lacrisert, 69

Lasers

in cataract surgery, 1, 142

in glaucoma surgery, 167–69 in LASIK surgery, 53–56

neodymium: YAG laser, 142, 167 in PRK surgery, 54, 55, 56

in treating diabetic retinopathy, 178–80 in treating macular degeneration, 209–10 in treating retinal tears, 212

335

I N D E X

in treatment of neovascularization,

Magnesium, 183–84, 298–99

221–22, 223

Manganese, 193, 301

LASIK (laser in situ keratomileusis), 53–56

Map-dot fingerprint dystrophy, 89–90

Latanoprost, 154–55

Marginal hypersensitivity ulcer, 61

Lattice degeneration, 211

Meals, and diurnal rhythm, 161–62

Lattice dystrophy, 90

Medical history, 22

Lazy eye. See Amblyopia

Medications. See also specific conditions;

Legal blindness, 25

specific medications

Lens

allergies and sensitivity to, 23

anatomy of, 10, 15–16

causing headaches, 250

artificial implants of, 56–57, 140

effect on optic nerve, 151

in cataracts, 122–23, 125–26

eyedrops

effect of LASIK on, 55

anesthetic (numbing), 84, 86

examination of, 33

artificial tears, 63–64, 68

protection from oxidation, 125–26

cycloplegic, 239

Lenses, eyeglasses. See also Contact lenses

in diagnosing disorders, 37

bifocals, 40–41, 44

dilating, 84, 138–39

glass or plastic, 42

getting into child’s eyes, 98

prescriptions for, 40–41

eye ointments, 63, 69, 83–84, 88

progressive addition, 44–45

patient history of, 22–23

tinting, 42

side effects of

trifocals, 44

anticancer drugs, 274–75

UV coating of, 42–43

antidepressants, 273–74

Levator muscle, 79–80, 81

anti-inflammatory drugs, 271–73

Lid hygiene/scrubs, 62

cholesterol-lowering drugs, 275

Lid myokymia, 7–8

sildenafil (Viagra), 276

Lutein

tranquilizers, 273–74

and macular degeneration, 131, 201–3, 205

tuberculosis drugs, 276

in preventing cataracts, 131–32, 142

Men, cholesterol and zinc in, 194

Lycopene, 199, 203

Merté, H.-J., 162

Lymph nodes, 30

Microaneurysms, 177–78, 179

 

Migraine headaches, 6, 246–50

Macula. See also Macular degeneration

Milk, 269

defined, 17, 188

Minerals

holes in, 214–15

calcium, 297–98

puckers in, 215

copper, 191–93, 300–301

in retinopathy, 178, 179–80

iodine, 302

testing for problems of, 36

iron, 193, 295–97

Macular degeneration

magnesium, 183–84, 298–99

and animal fats, 203–6

manganese, 193, 301

antioxidants in, 197–203, 205

phosphorus, 299

and cataracts, 137

selenium, 301–2

causes of, 189–90

zinc, 190–97, 299–300

development of, 188

Mohs’s micrographic surgery, 77

lifestyle related risks, 199, 206–7

Molluscum contagiosum, 75, 267–68

and lutein, 131, 201–3, 205

Monofixation syndrome, 112

self-monitoring in, 207–8

Monovision, 48

surgery for, 209–10

Motility (eye movement), 30–31

symptoms of, 187–88

Multiple sclerosis (MS), 119, 228–29

types of, 189

Muscle relaxation techniques, 245–46

and visual acuity, 26

Muscles, eye

and zinc, 190–97, 205, 206

ciliary, 14

Macular dystrophy, 90

disorders of, 36–37

Macular edema, 275

amblyopia, 111–12

Maculopathy, diabetic, 179

double vision, 116–20

336

I N D E X

esophoria, 115

magnesium, 183–84, 298–99

esotropia, 108–11

manganese, 193, 301

exophoria, 115

phosphorus, 299

exotropia, 112–15

selenium, 301–2

imbalances of, 120

zinc, 190–97, 299–300

external, 18–19, 109

and optic nerve damage, 233

levator, 79–80, 81

phytochemicals in, 302–4

Myasthenia gravis, 80–81, 117

in prevention of disease, 3, 277–79

Mycobacterium avium intracellulare, 266

protein in, 180, 191, 280–83

Myopia (nearsightedness), 26, 28, 39, 53

and retinopathy, 180–82

 

vitamins in

Nasolacrimal duct, 30, 70–73

biotin, 291

Nearsightedness (myopia), 26, 28, 39, 53

folate, 291

Neodymium: YAG laser, 142, 167

pantothenic acid, 291

Neovascular glaucoma, 221

supplements, 3, 127–28, 206

Neovascularization

vitamin A, 286–87

defined, 221–22

vitamin B1 (thiamin), 160, 287

and laser treatments, 178–79

vitamin B2 (riboflavin), 132, 287–88

subretinal, 223

vitamin B3 (niacin), 132, 275, 288

Nerves

vitamin B6 (pyridoxine), 288–89

cranial, 117–18

vitamin B12 (cobalamin), 233, 289–90

palsy of, 117–19, 250

vitamin C, 125, 129–30, 143, 159–60,

problems with in ptosis, 80

292

Neuralgia

vitamin D, 292–93

greater occipital, 244, 245

vitamin E, 125, 130–31, 143, 293–94

postherpetic, 261–62, 263

vitamin K, 294

Niacin (vitamin B3), 132, 275, 288

 

Nicotinic acid. See Niacin

Obesity, 135, 174

NIDDM (non-insulin-dependent diabetes

Occipital cortex, 18

mellitus), 173–74, 183

Ocular histo, 222–24

Nodular episcleritis, 102, 103

Ocular hypertensives, 146

Nolvadex (tamoxifen), 274

Oil gland tumors, 74–75

Non-insulin-dependent diabetes mellitus

Ointments, eye

(NIDDM), 173–75, 183

in treating abrasions, 83–84

Nuclear sclerotic cataracts, 16, 123, 124, 135

in treating blepharitis, 63

Nucleus of lens, 15, 123

in treating corneal edema, 88

Nutrition

in treating dry eye syndrome, 69

and blepharitis, 62–63

Omega-3 fatty acids, 284

and blood viscosity, 165–67

effect on retinopathy, 185

carbohydrates in, 279–80

and glaucoma, 165–66

and cataracts, 126–35

in infant eye health, 269–71

and diabetes, 174–76

Omega-6 fatty acids, 269, 284

fats in, 278, 283–85

Open angle glaucoma, chronic

fiber in, 285–86

blood circulation in, 151

food as source of nutrients, 200

defined, 14, 149, 150

in infant vision, 268–71

effect of medications on, 273–74

leafy green vegetables in, 202–3, 205, 206

and omega-3 fatty acids in, 165

low carbohydrate, high protein diet in, 3

surgery for, 168–70

and macular degeneration, 190–206

Ophthalmodynamometry, 35–36

and migraine headaches, 250

Ophthalmologists, 216–17

minerals in

Ophthalmometers, 49

calcium, 297–98

Ophthalmopathy, thyroid, 251–54

copper, 191–93, 300–301

Ophthalmoscopes, 34–35

iodine, 302

Optic cup, 18

iron, 193, 295–97

Optic disk, 18, 34, 146–47

337